title: Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury.
authors: Wei
authors: W
authors: Wang
authors: Penghui
authors: P
authors: Yang
authors: Ying
authors: Y
authors: Zhong
authors: Zhongpeng
authors: Z
authors: Zhao
authors: Li
authors: L
authors: Xing
authors: Yan
authors: Y
authors: Zhao
authors: Zhen
authors: Z
authors: Zou
authors: Yanli
authors: Y
authors: Zhang
authors: Chenggang
authors: C
authors: Li
authors: Taisheng
authors: T
authors: Li
authors: Chen
authors: C
authors: Wang
authors: Zhong
authors: Z
authors: Wang
authors: Xuezhong
authors: X
authors: Yu
authors: Bin
authors: B
authors: Cao
authors: Xiang
authors: X
authors: Gao
authors: Josef M
authors: JM
authors: Penninger
authors: Xiliang
authors: X
authors: Wang
authors: Chengyu
authors: C
authors: Jiang
mesh_terms: D055371:Acute Lung Injury / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D054357:Chemokine CXCL10 / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000276:immunology*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000254:growth & development / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D009976:Orthomyxoviridae Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D054357:Chemokine CXCL10; C485433:Cxcl10 protein, mouse